Intrinsiqs

Is Clarity Pharmaceuticals Ltd overvalued?

Clarity Pharmaceuticals Ltd (CU6.AX) — key valuation metrics and fundamentals.

No verdict
Price
$2.14
Fair value
Current P/E
Normal P/E
Market cap
$798.2M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares CU6.AX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.